Home›Diabetes & Endocrinology› AI models demonstrate high accuracy in predicting progression from Gestational Diabetes to Type 2 Diabetes
AI models demonstrate high accuracy in predicting progression from Gestational Diabetes to Type 2 DiabetesArtificial intelligence helps predict type 2 diabetes after pregnancy
Journal of medical Internet researchPublished July 10, 2026Study authors: Abd-Alrazaq Alaa, Mohamed Shahira Padinharepattel, Alajlani Mohannad, Tabassum Aliya, Ordóñez-Mena J…PubMed ↗DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Note that AI models show high accuracy for predicting T2DM after GDM, but evidence is limited by high heterogeneity.
This systematic review and meta-analysis synthesized data from 10 studies to evaluate the performance of Artificial Intelligence (AI) models in predicting progression from Gestational Diabetes Mellitus (GDM) to Type 2 Diabetes Mellitus (T2DM) or prediabetes. The analysis focused on metrics including accuracy, sensitivity, specificity, F1-score, and Area Under the Curve (AUC).
The meta-analysis reported high predictive performance for T2DM, with an accuracy of 0.85 (95% CI 0.79-0.90), sensitivity of 0.89 (95% CI 0.81-0.95), and specificity of 0.88 (95% CI 0.81-0.93). The F1-score for T2DM was 0.80 (95% CI 0.75-0.85), while the AUC for T2DM prediction was 0.86 (95% CI 0.77-0.91). In contrast, the AUC for predicting prediabetes was lower at 0.69 (95% CI 0.60-0.77).
The authors noted several limitations, including small sample sizes, high heterogeneity, a lack of external validation, and a high risk of bias. These factors limit the certainty of the findings. Despite these limitations, the results suggest that AI-driven tools could potentially be integrated into electronic health records or postpartum care pathways to facilitate early identification and targeted prevention for women with a history of GDM.
How this fits prior evidence
This meta-analysis addresses a gap in identifying automated screening tools for post-pregnancy complications. It extends prior evidence regarding prediction models for Type 2 Diabetes, which previously showed high accuracy for progression from prediabetes to T2DM but required more external validation. While the current findings show high predictive performance for T2DM following GDM (AUC 0.86), the underlying data are limited by heterogeneity and risk of bias.
For many women, a diagnosis of gestational diabetes during pregnancy brings a mix of relief and worry about the future. It often signals a higher risk of developing type 2 diabetes or prediabetes later in life. Identifying who is at the highest risk early on can help doctors provide better support and earlier prevention steps.
A review of ten studies found that artificial intelligence models performed well at predicting these outcomes. Specifically, these computer models showed high accuracy and sensitivity when identifying women who would progress to type 2 diabetes. The models also showed modest performance in predicting prediabetes.
While the results are promising for integrating into health records to catch risks early, there are important notes of caution. The evidence comes from a small number of studies with significant differences between them and a lack of outside testing. Because of these factors, while the technology shows potential, it is still in an early stage of development.
What this means for you:
AI models show high accuracy in predicting if gestational diabetes will lead to type 2 diabetes later.
Common questions
How accurate are these AI models at predicting type 2 diabetes?
The artificial intelligence models showed high performance for predicting type 2 diabetes. They achieved an accuracy of 0.85 and a sensitivity of 0.89. These scores suggest the models are quite effective at identifying women who may progress from gestational diabetes to type 2 diabetes.
Can AI predict if I will develop prediabetes?
The AI models showed modest performance when predicting prediabetes, with an area under the curve of 0.69. While they are less certain about prediabetes than type 2 diabetes, they still provide some level of predictive insight.
Is this technology ready to be used in clinics today?
While the results show potential for use in electronic health records and postpartum care, the evidence is currently limited. The study noted small sample sizes, high variation between studies, and a lack of external validation, meaning more research is needed.
BACKGROUND: Gestational diabetes mellitus (GDM) significantly increases the risk of developing type 2 diabetes mellitus (T2DM) post partum, with up to half of affected women progressing within a decade. Early identification of high-risk individuals is critical for implementing preventive interventions. Artificial intelligence (AI) offers enhanced predictive capabilities that can substantially enhance the prevention of postpartum diabetes.
OBJECTIVE: This systematic review and meta-analysis aimed to evaluate the performance of AI models in predicting the progression from GDM to T2DM or prediabetes.
METHODS: A total of 7 databases (MEDLINE, Embase, Scopus, Web of Science, IEEE Xplore, ACM Digital Library, and Google Scholar) were systematically searched from inception through September 12, 2025, supplemented by backward and forward reference screening and biweekly alerts to capture newly published studies. This review included peer-reviewed English-language studies that applied AI algorithms to predict T2DM or prediabetes among women with previous GDM. Eligible studies focused on human participants; reported performance metrics (eg, accuracy, sensitivity, and specificity); and excluded non-AI models, animal studies, reviews, protocols, abstracts, and non-English publications. Moreover, 2 reviewers independently conducted study selection, data extraction, and risk of bias assessment using the PROBAST (Prediction Model Risk of Bias Assessment Tool)+AI tool. Pooled estimates were computed using random-effects meta-analysis models.
RESULTS: In total, 10 studies met the inclusion criteria, of which 8 were eligible for meta-analysis. The reviewed studies spanned from 2011 to 2025 and were conducted across 7 countries, predominantly in the United States (3/10, 30%). Most publications were journal articles (9/10, 90%), and retrospective designs (6/10, 60%) were slightly more common than prospective designs (4/10, 40%). AI models demonstrated high predictive performance for T2DM, with pooled accuracy of 0.85 (95% CI 0.79-0.90; prediction interval [PI] 0.64-0.98), sensitivity of 0.89 (95% CI 0.81-0.95; PI 0.63-1.00), specificity of 0.88 (95% CI 0.81-0.93; PI 0.67-0.99), F1-score of 0.80 (95% CI 0.75-0.85; PI 0.68-0.93), and area under the curve of 0.86 (95% CI 0.77-0.91; PI 0.54-0.97). However, AI performance for prediabetes prediction was modest (area under the curve=0.69, 95% CI 0.60-0.77). Subgroup analyses showed that random forest, decision tree, logistic regression, and naïve Bayes models performed comparably. Fasting plasma glucose and BMI were the most identified significant predictors in the included studies.
CONCLUSIONS: AI models show potential in predicting T2DM after GDM. However, evidence remains limited by small sample sizes, high heterogeneity, lack of external validation, and high risk of bias. Our findings have important implications for digital health, supporting the integration of AI-driven risk prediction into electronic health record systems and postpartum care pathways to enable early identification, targeted prevention, and improved long-term outcomes. Future research should use large, diverse cohorts, integrate multidimensional data, adopt standardized reporting frameworks, and encourage open-access data sharing.
